Position in INCY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,108,042
+$409,647 QoQ
Shares Held
18,596
+3.1% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#323
of 849 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Osmosis Investment Management UK Ltd holds $17,095,941 across 7 Biotechnology names. INCY ranks #2 (12.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
21,075 | $10,468,584 | |
| 2 | INCY |
Incyte Corp
This page
|
18,596 | $2,108,042 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,817 | $1,756,512 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,638 | $1,095,147 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
3,447 | $645,554 | |
| 6 | INSM |
INSMED Inc
|
4,926 | $525,210 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,862 | $496,892 |
All Filings in INCY
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,108,042 | 18,596 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,698,395 | 18,045 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $5,104,729 | 51,683 | Shares | Sole | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||